Trade DarioHealth Corp. - DRIO CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026346% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004124% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
DarioHealth Corp ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 1.58 |
Open* | 1.64 |
1-Year Change* | -66.39% |
Day's Range* | 1.54 - 1.87 |
52 wk Range | 0.68-6.78 |
Average Volume (10 days) | 116.10K |
Average Volume (3 months) | 3.66M |
Market Cap | 28.30M |
P/E Ratio | -100.00K |
Shares Outstanding | 27.21M |
Revenue | 23.55M |
EPS | -2.20 |
Dividend (Yield %) | N/A |
Beta | 1.38 |
Next Earnings Date | Mar 7, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 4, 2023 | 1.58 | 0.22 | 16.18% | 1.36 | 1.60 | 1.36 |
Dec 1, 2023 | 1.38 | 0.24 | 21.05% | 1.14 | 1.39 | 1.14 |
Nov 30, 2023 | 1.19 | -0.05 | -4.03% | 1.24 | 1.26 | 1.15 |
Nov 29, 2023 | 1.27 | 0.23 | 22.12% | 1.04 | 1.28 | 1.04 |
Nov 28, 2023 | 1.02 | -0.03 | -2.86% | 1.05 | 1.07 | 1.00 |
Nov 27, 2023 | 1.06 | 0.02 | 1.92% | 1.04 | 1.09 | 1.02 |
Nov 24, 2023 | 1.03 | 0.04 | 4.04% | 0.99 | 1.04 | 0.97 |
Nov 22, 2023 | 0.98 | -0.03 | -2.97% | 1.01 | 1.03 | 0.98 |
Nov 21, 2023 | 1.02 | -0.08 | -7.27% | 1.10 | 1.10 | 1.02 |
Nov 20, 2023 | 1.11 | -0.19 | -14.62% | 1.30 | 1.30 | 1.09 |
Nov 17, 2023 | 1.17 | 0.18 | 18.18% | 0.99 | 1.20 | 0.99 |
Nov 16, 2023 | 0.99 | 0.00 | 0.00% | 0.99 | 1.02 | 0.99 |
Nov 15, 2023 | 1.02 | 0.05 | 5.15% | 0.97 | 1.07 | 0.97 |
Nov 14, 2023 | 1.00 | -0.04 | -3.85% | 1.04 | 1.06 | 0.99 |
Nov 13, 2023 | 1.01 | -0.02 | -1.94% | 1.03 | 1.05 | 0.96 |
Nov 10, 2023 | 1.04 | 0.02 | 1.96% | 1.02 | 1.11 | 1.02 |
Nov 9, 2023 | 1.06 | -0.13 | -10.92% | 1.19 | 1.19 | 1.05 |
Nov 8, 2023 | 1.17 | -0.09 | -7.14% | 1.26 | 1.27 | 1.15 |
Nov 7, 2023 | 1.29 | -0.02 | -1.53% | 1.31 | 1.33 | 1.24 |
Nov 6, 2023 | 1.29 | -0.05 | -3.73% | 1.34 | 1.40 | 1.27 |
DarioHealth Corp. Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, December 7, 2023 | ||
Time (UTC) 14:00 | Country IL
| Event DarioHealth Corp Annual Shareholders Meeting DarioHealth Corp Annual Shareholders MeetingForecast -Previous - |
Monday, December 11, 2023 | ||
Time (UTC) 14:00 | Country IL
| Event DarioHealth Corp Annual Shareholders Meeting DarioHealth Corp Annual Shareholders MeetingForecast -Previous - |
Thursday, March 7, 2024 | ||
Time (UTC) 13:30 | Country IL
| Event Q4 2023 DarioHealth Corp Earnings Release Q4 2023 DarioHealth Corp Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 27.656 | 20.513 | 7.576 | 7.559 | 7.394 |
Revenue | 27.656 | 20.513 | 7.576 | 7.559 | 7.394 |
Cost of Revenue, Total | 18.001 | 16.55 | 5.063 | 4.962 | 5.629 |
Gross Profit | 9.655 | 3.963 | 2.513 | 2.597 | 1.765 |
Total Operating Expense | 88.931 | 97.007 | 37.479 | 25.264 | 25.082 |
Selling/General/Admin. Expenses, Total | 46.816 | 63.238 | 27.983 | 16.61 | 15.777 |
Research & Development | 19.649 | 17.219 | 4.433 | 3.692 | 3.676 |
Unusual Expense (Income) | 4.465 | ||||
Operating Income | -61.275 | -76.494 | -29.903 | -17.705 | -17.688 |
Interest Income (Expense), Net Non-Operating | -0.107 | -0.151 | 0.507 | -0.004 | -0.115 |
Other, Net | -0.807 | -0.084 | -0.049 | -0.027 | |
Net Income Before Taxes | -62.189 | -76.729 | -29.445 | -17.736 | -17.803 |
Net Income After Taxes | -62.193 | -76.761 | -29.445 | -17.736 | -17.803 |
Net Income Before Extra. Items | -62.193 | -76.761 | -29.445 | -17.736 | -17.803 |
Net Income | -62.193 | -76.761 | -29.445 | -17.736 | -17.803 |
Total Adjustments to Net Income | -1.643 | -2.005 | -3.658 | -3.155 | -0.493 |
Income Available to Common Excl. Extra. Items | -63.836 | -78.766 | -33.103 | -20.891 | -18.296 |
Income Available to Common Incl. Extra. Items | -63.836 | -78.766 | -33.103 | -20.891 | -18.296 |
Diluted Net Income | -63.836 | -78.766 | -33.103 | -20.891 | -18.296 |
Diluted Weighted Average Shares | 23.635 | 16.5917 | 5.96331 | 2.26614 | 1.17064 |
Diluted EPS Excluding Extraordinary Items | -2.70091 | -4.74731 | -5.55112 | -9.21878 | -15.629 |
Diluted Normalized EPS | -2.57811 | -4.71283 | -5.55112 | -9.21878 | -15.629 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 6.152 | 7.066 | 6.809 | 6.605 | 6.183 |
Revenue | 6.152 | 7.066 | 6.809 | 6.605 | 6.183 |
Cost of Revenue, Total | 4.078 | 3.898 | 4.077 | 4.805 | 5.045 |
Gross Profit | 2.074 | 3.168 | 2.732 | 1.8 | 1.138 |
Total Operating Expense | 23.839 | 19.263 | 19.155 | 22.316 | 23.529 |
Selling/General/Admin. Expenses, Total | 10.872 | 10.411 | 6.96 | 11.57 | 14.356 |
Research & Development | 5.222 | 5.165 | 4.782 | 4.803 | 4.137 |
Operating Income | -17.687 | -12.197 | -12.346 | -15.711 | -17.346 |
Interest Income (Expense), Net Non-Operating | 1.621 | -0.579 | -0.244 | 0.093 | 0.062 |
Other, Net | -0.519 | -0.049 | -0.024 | -0.014 | -0.743 |
Net Income Before Taxes | -16.585 | -12.825 | -12.614 | -15.632 | -18.027 |
Net Income After Taxes | -16.585 | -12.825 | -12.617 | -15.632 | -18.028 |
Net Income Before Extra. Items | -16.585 | -12.825 | -12.617 | -15.632 | -18.028 |
Net Income | -16.585 | -12.825 | -12.617 | -15.632 | -18.028 |
Total Adjustments to Net Income | -1.691 | 0 | -0.265 | -0.494 | -0.433 |
Income Available to Common Excl. Extra. Items | -18.276 | -12.825 | -12.882 | -16.126 | -18.461 |
Income Available to Common Incl. Extra. Items | -18.276 | -12.825 | -12.882 | -16.126 | -18.461 |
Diluted Net Income | -18.276 | -12.825 | -12.882 | -16.126 | -18.461 |
Diluted Weighted Average Shares | 28.1863 | 27.57 | 25.911 | 22.9732 | 22.426 |
Diluted EPS Excluding Extraordinary Items | -0.6484 | -0.46518 | -0.49716 | -0.70195 | -0.8232 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.5183 | -0.47283 | -0.41348 | -0.65241 | -0.82346 |
Unusual Expense (Income) | 3.667 | -0.211 | 3.336 | 1.138 | -0.009 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 65.524 | 45.605 | 34.128 | 22.939 | 13.313 |
Cash and Short Term Investments | 49.522 | 36 | 28.777 | 20.586 | 11.177 |
Cash & Equivalents | 49.357 | 35.808 | 28.59 | 20.395 | 10.997 |
Short Term Investments | 0.165 | 0.192 | 0.187 | 0.191 | 0.18 |
Total Receivables, Net | 6.899 | 1.71 | 1.624 | 0.672 | 0.759 |
Accounts Receivable - Trade, Net | 6.416 | 1.31 | 0.124 | 0.672 | 0.168 |
Total Inventory | 7.956 | 6.228 | 2.293 | 1.414 | 1.377 |
Prepaid Expenses | 0.908 | 1.591 | 1.354 | 0.203 | |
Other Current Assets, Total | 0.239 | 0.076 | 0.08 | 0.064 | |
Total Assets | 119.191 | 100.771 | 35.407 | 24.569 | 14.089 |
Property/Plant/Equipment, Total - Net | 1.994 | 0.989 | 1.074 | 1.413 | 0.733 |
Property/Plant/Equipment, Total - Gross | 3.433 | 2.215 | 1.866 | 2.024 | |
Accumulated Depreciation, Total | -1.439 | -1.226 | -0.792 | -0.611 | |
Other Long Term Assets, Total | 0.117 | 0.077 | 0.205 | 0.217 | 0.043 |
Total Current Liabilities | 19.35 | 14.376 | 7.034 | 5.22 | 5.164 |
Accounts Payable | 2.322 | 5.109 | 2.48 | 1.656 | 2.574 |
Accrued Expenses | 6.885 | 8.072 | 3.33 | 2.341 | |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 1.32 | 1.195 | 1.224 | 1.223 | 2.59 |
Total Liabilities | 39.192 | 15.222 | 7.256 | 5.675 | 5.164 |
Total Long Term Debt | 18.105 | 0 | 0 | 0 | 0 |
Long Term Debt | 18.105 | ||||
Other Liabilities, Total | 1.737 | 0.846 | 0.222 | 0.455 | 0 |
Total Equity | 79.999 | 85.549 | 28.151 | 18.894 | 8.925 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.003 | 0.002 | 0.00081 | 0.00022 | 0.008 |
Additional Paid-In Capital | 365.846 | 307.561 | 171.399 | 129.039 | 98.171 |
Retained Earnings (Accumulated Deficit) | -285.85 | -222.014 | -143.248 | -110.145 | -89.254 |
Total Liabilities & Shareholders’ Equity | 119.191 | 100.771 | 35.407 | 24.569 | 14.089 |
Total Common Shares Outstanding | 25.7245 | 16.5734 | 8.11949 | 2.23565 | 1.83039 |
Total Preferred Shares Outstanding | 0.00357 | 0.01193 | 0.01582 | 0 | 0 |
Other Equity, Total | -0.00081 | -0.00022 | |||
Goodwill, Net | 41.64 | 41.64 | |||
Intangibles, Net | 9.916 | 12.46 | |||
Current Port. of LT Debt/Capital Leases | 8.823 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 56.211 | 65.777 | 55.476 | 65.524 | 71.582 |
Cash and Short Term Investments | 44.273 | 52.995 | 43.318 | 49.522 | 57.257 |
Cash & Equivalents | 43.878 | 52.602 | 38.789 | 49.357 | 57.081 |
Short Term Investments | 0.395 | 0.393 | 4.529 | 0.165 | 0.176 |
Total Receivables, Net | 6.467 | 6.868 | 5.281 | 8.046 | 6.563 |
Accounts Receivable - Trade, Net | 4.533 | 4.821 | 2.797 | 6.416 | 4.521 |
Total Inventory | 5.471 | 5.914 | 6.877 | 7.956 | 7.762 |
Total Assets | 106.505 | 117.159 | 108.009 | 119.191 | 126.334 |
Property/Plant/Equipment, Total - Net | 1.977 | 1.888 | 1.935 | 1.994 | 2.032 |
Goodwill, Net | 41.64 | 41.64 | 41.64 | 41.64 | 41.64 |
Intangibles, Net | 6.541 | 7.678 | 8.803 | 9.916 | 11.053 |
Other Long Term Assets, Total | 0.136 | 0.176 | 0.155 | 0.117 | 0.027 |
Total Current Liabilities | 8.106 | 8.076 | 17.617 | 19.35 | 11.524 |
Accounts Payable | 1.929 | 1.451 | 1.883 | 2.322 | 1.982 |
Accrued Expenses | 0.119 | 0.145 | 0.291 | 0.293 | 0.27 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.684 | 0.789 | 0.925 | 1.32 | 2.76 |
Total Liabilities | 38.47 | 38.755 | 35.979 | 39.192 | 37.388 |
Total Long Term Debt | 29 | 29.094 | 16.745 | 18.105 | 24.046 |
Other Liabilities, Total | 1.364 | 1.585 | 1.617 | 1.737 | 1.818 |
Total Equity | 68.035 | 78.404 | 72.03 | 79.999 | 88.946 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.003 | 0.003 | 0.003 | 0.003 | 0.002 |
Additional Paid-In Capital | 401.887 | 395.352 | 370.702 | 365.846 | 361.912 |
Retained Earnings (Accumulated Deficit) | -333.855 | -316.951 | -298.675 | -285.85 | -272.968 |
Other Equity, Total | |||||
Total Liabilities & Shareholders’ Equity | 106.505 | 117.159 | 108.009 | 119.191 | 126.334 |
Total Common Shares Outstanding | 27.2152 | 26.7847 | 25.8753 | 25.7245 | 23.291 |
Total Preferred Shares Outstanding | 0.01896 | 0.01896 | 0.00356 | 0.00357 | 0.00991 |
Payable/Accrued | 5.374 | 5.691 | 5.935 | 6.592 | 6.512 |
Long Term Debt | 29 | 29.094 | 16.745 | 18.105 | 24.046 |
Current Port. of LT Debt/Capital Leases | 0 | 8.583 | 8.823 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -62.193 | -76.761 | -29.445 | -17.736 | -17.803 |
Cash From Operating Activities | -47.845 | -50.409 | -17.736 | -15.725 | -11.47 |
Cash From Operating Activities | 0.356 | 0.282 | 0.19 | 0.183 | 0.207 |
Non-Cash Items | 20.108 | 26.322 | 11.369 | 2.625 | 3.758 |
Changes in Working Capital | -10.477 | -3.287 | 0.15 | -0.797 | 2.368 |
Cash From Investing Activities | -0.573 | -8.134 | -1.622 | -0.113 | 0.006 |
Capital Expenditures | -0.573 | -0.261 | -0.118 | -0.098 | -0.071 |
Other Investing Cash Flow Items, Total | 0 | -7.873 | -1.504 | -0.015 | 0.077 |
Cash From Financing Activities | 61.94 | 65.766 | 27.548 | 25.247 | 18.743 |
Issuance (Retirement) of Stock, Net | 38.154 | 65.766 | 27.548 | 25.247 | 18.743 |
Net Change in Cash | 13.522 | 7.223 | 8.19 | 9.409 | 7.279 |
Amortization | 4.361 | 3.035 | |||
Cash Interest Paid | 1.876 | ||||
Issuance (Retirement) of Debt, Net | 23.786 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -12.825 | -62.193 | -49.576 | -33.944 | -15.916 |
Cash From Operating Activities | -4.757 | -47.845 | -39.904 | -29.209 | -18.094 |
Cash From Operating Activities | 0.097 | 0.356 | 0.243 | 0.154 | 0.07 |
Amortization | 1.113 | 4.361 | 3.224 | 2.087 | 0.963 |
Non-Cash Items | 4.585 | 20.108 | 13.818 | 9.303 | 5.35 |
Changes in Working Capital | 2.273 | -10.477 | -7.613 | -6.809 | -8.561 |
Cash From Investing Activities | -4.362 | -0.573 | -0.514 | -0.34 | -0.181 |
Capital Expenditures | -0.074 | -0.573 | -0.514 | -0.34 | -0.181 |
Other Investing Cash Flow Items, Total | -4.288 | 0 | 0 | 0 | 0 |
Cash From Financing Activities | -1.389 | 61.94 | 61.675 | 61.675 | 38.023 |
Issuance (Retirement) of Stock, Net | 38.154 | 37.889 | 37.889 | 38.023 | |
Net Change in Cash | -10.508 | 13.522 | 21.257 | 32.126 | 19.748 |
Cash Interest Paid | 1.072 | 1.876 | 0.969 | 0.181 | |
Issuance (Retirement) of Debt, Net | -1.389 | 23.786 | 23.786 | 23.786 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Nantahala Capital Management, LLC | Hedge Fund | 8.8854 | 2418507 | 0 | 2023-06-30 | MED |
Phoenix Investment and Finances Ltd | Investment Advisor | 4.9268 | 1341027 | 0 | 2023-06-30 | MED |
More Investment House Ltd. | Investment Advisor/Hedge Fund | 4.7339 | 1288518 | -178202 | 2023-09-30 | LOW |
Appian Way Asset Management LP | Investment Advisor/Hedge Fund | 4.7069 | 1281158 | 258376 | 2023-06-30 | HIGH |
Clal Insurance Enterprises Holdings Ltd. | Investment Advisor | 3.9185 | 1066561 | 0 | 2023-06-30 | LOW |
Kershner Trading Americas, L.L.C. | Corporation | 3.8687 | 1053024 | -180500 | 2023-09-08 | LOW |
Raphael (Erez) | Individual Investor | 2.9484 | 802521 | 91777 | 2023-03-03 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.0601 | 288549 | 0 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9188 | 250099 | 55704 | 2023-06-30 | LOW |
Ben-David (Zvi) | Individual Investor | 0.9139 | 248765 | 26455 | 2023-03-03 | LOW |
Stern (Adam K.) | Individual Investor | 0.6526 | 177634 | 122026 | 2023-03-03 | MED |
Bacher (Dror) | Individual Investor | 0.6229 | 169533 | 40515 | 2023-03-03 | MED |
Shaked (Yoav) | Individual Investor | 0.441 | 120042 | 9102 | 2023-03-03 | LOW |
MAI Capital Management, LLC | Investment Advisor/Hedge Fund | 0.3946 | 107394 | -38406 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.3887 | 105800 | -37187 | 2023-06-30 | LOW |
Shay Capital LLC | Hedge Fund | 0.3674 | 100000 | 0 | 2023-06-30 | HIGH |
LPL Financial LLC | Investment Advisor | 0.3391 | 92301 | 5735 | 2023-06-30 | LOW |
Karah (Hila) | Individual Investor | 0.3095 | 84255 | 10025 | 2023-03-03 | MED |
Matheis (Dennis) | Individual Investor | 0.282 | 76747 | -29127 | 2023-03-03 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.248 | 67497 | 0 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
DarioHealth Corp. Company profile
About DarioHealth Corp
DarioHealth Corp.(DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. DarioHealth offers digital therapeutics solutions covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. DarioHealth products include Dario blood glucose monitoring, Dario Blood Pressure Monitoring System, and Dario Smart Scale. The Dario blood glucose monitoring device is a system that measure sugar levels. The Dario Smart Scale is a blood pressure monitoring system used to measure blood pressure and stored in a digital logbook in the Dario App. It offers modular platform integrating digital therapeutics, coaching, devices, and care providers. Its suite of offerings includes Dario Tools, DarioEngage, and Dario Loop.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, DarioHealth Corp revenues increased from $7.6M to $20.5M. Net loss applicable to common stockholders increased from $33.1M to $78.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Marketing and Pre-Production Cost increase from $12.5M to $33.7M (expense).
Equity composition
Common Stock $0.0001 Par, Shares auth. 45M and o/s 19,240,234 issd. Insiders own approx. 14.03% (after the IPO). If no information is provided, use TBA. 10/14 1-for-5 reverse stock split. 03/2016, 1-For-18 Reverse Stock Split.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
18 W 18Th St., 5Th Floor
NEW YORK
NEW YORK 10011
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com